CVC Capital Partners has announced that former Allergan executive Anish Mehta will be appointed as CEO of the international women’s health assets portfolio which CVC Fund VI will be acquiring from Teva. Anish was head of international business development at Allergan, where he led the $40.5 billion divestment of the Actavis Global Generics business to Teva. Prior to this, Anish had responsibility for the European and Middle East businesses for Actavis.